Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial
- Authors
- Kim, Eun Hye; Lee, Yong Chan; Chang, Young Woon; Park, Jong-Jae; Chun, Hoon Jai; Jung, Hwoon-Yong; Kim, Hyun-Soo; Jeong, Hyun Yong; Seol, Sang-Young; Han, Sok Won; Choi, Myung-Gyu; Park, Soo-Heon; Lee, Ok-Jae; Jung, Jin Tae; Lee, Dong Ho; Jung, Hyun Chae; Lee, Soo Teik; Kim, Jae Gyu; Youn, Sei Jin; Kim, Hak Yang; Lee, Sang Woo
- Issue Date
- Jun-2015
- Publisher
- Springer New York LLC
- Keywords
- Famotidine; Lafutidine; Omeprazole; Reflux esophagitis
- Citation
- Digestive Diseases and Sciences, v.60, no.6, pp 1724 - 1732
- Pages
- 9
- Journal Title
- Digestive Diseases and Sciences
- Volume
- 60
- Number
- 6
- Start Page
- 1724
- End Page
- 1732
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/11351
- DOI
- 10.1007/s10620-014-3489-4
- ISSN
- 0163-2116
1573-2568
- Abstract
- Background: There has been no study on the efficacy of lafutidine for patients with reflux esophagitis in Korea. Aim: To evaluate the efficacy of a new-generation histamine-2 receptor antagonist, lafutidine, in comparison with famotidine in patients with reflux esophagitis. Methods: This was a randomized, double-blind, non-inferiority trial enrolling patients with erosive esophagitis. The efficacy and safety of 20 mg lafutidine (treatment group) were compared with those of 40 mg famotidine (control group) and 20 mg omeprazole (reference group). The primary endpoint was the complete healing rates of reflux esophagitis on endoscopy after 8 weeks of treatment. The non-inferiority margin was assumed to be −15 %. Results: The healing rates of reflux esophagitis on endoscopy after 8 weeks of treatment were 70.14 % (101/144) in the lafutidine, 63.45 % (92/145) in the famotidine, and 85.71 % (126/147) in the omeprazole group. The difference in healing rates between the lafutidine and famotidine groups was 6.69 % (95 % confidence interval = [−4.14 to 17.52]). In addition, lafutidine was superior to famotidine in clinical improvement (53.73 % vs. 39.55 %, P = 0.0200). Conclusions: Lafutidine was non-inferior to famotidine in healing of reflux esophagitis. Lafutidine, however, was superior to famotidine in terms of symptom relief of reflux esophagitis. © 2014, Springer Science+Business Media New York.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/11351)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.